Clinical Trials Logo

Sterility, Female clinical trials

View clinical trials related to Sterility, Female.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05518175 Recruiting - Sterility, Female Clinical Trials

Patient-centered Outcomes After Permanent Female Sterilization Procedure(POPS Trial)

POPS
Start date: November 15, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to compare and capture key elements of the patient experience, quality of recovery, preferences and satisfaction after laparoscopic salpingectomy done via 3 different routes.

NCT ID: NCT05279560 Recruiting - Infertility, Female Clinical Trials

Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation

OPIF
Start date: March 17, 2022
Phase: N/A
Study type: Interventional

The primary objective is to investigate the efficacy, defined as an increase in oocyte numbers upon ovarian stimulation, and safety of a single intra-ovarian PRP injection vs. saline solution (NaCl) injection (Placebo) transvaginally or laparoscopically for follicular activation in patients with child wish and with low ovarian reserve/expected poor ovarian response planning to undergo IVF or ICSI using own eggs. Pain score as numerical rating score and validated quality of life questionnaire will be requested after the procedure. Longterm follow-up of all participants will be performed 1, 2 and 5 years after end of study.

NCT ID: NCT04314869 Recruiting - Sterility, Female Clinical Trials

Uterus Transplantation Procedure From a Live Donor

Start date: May 23, 2020
Phase: N/A
Study type: Interventional

Absolut uterine factor, meaning the absence of uterus, represents a cause for sterility without the possibility of a present treatment. The uterine factor affects millions of women and may be due to congenital problems, such as the Muller anomalies (Mayer Rockitansky Syndrome) or acquired by previous hysterectomy or intrauterine adhesions (Asherman's Syndrome). The uterine transplant would represent the only possibility for patients with an absolute uterine factor to achieve both genetic and gestational maternity.